Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating
Greenhaven Road Capital's Q2 2026 investor letter highlights Cellebrite DI Ltd. (NASDAQ:CLBT) as a standout holding. The digital forensics company, headquartered in Petah Tikva, Israel, offers solutions to law enforcement, military, and other customers. On August 17, 2026, Cellebrite closed at $10.44 per share, with a market capitalization of $2.62 billion.
In the past year, the stock has seen a 33.92% drop and a one-month return of -29.22%. Despite recent declines and concerns about AI replacing software, Greenhaven Road Capital maintains a non-consensus view that AI will ultimately benefit Cellebrite. The company released its first AI product in early June, designed to assist investigators and offer a unique advantage over traditional language models.
Cellebrite is not on the list of the 40 most popular stocks among hedge funds heading into 2026, but the fund does acknowledge its potential as an investment.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
